Vivoryon Therapeutics AG Financial Overview
Vivoryon Therapeutics AG's market cap is currently €45.01M. The company's EPS TTM is €; its P/E ratio is ―; Vivoryon Therapeutics AG is scheduled to report earnings on December 4, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.